Market-Moving News for February 5th
Market-Moving News for February 5th
FDMT: 86% | 4DMT Presents Interim Data From Randomized Phase 2 PRISM Clinical Trial Of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity In Wet AMD
FDMT：86% | 4DMT 公佈了來自 Vitreal 4D-150 的隨機二期 PRISM 臨床試驗的中期數據，該試驗顯示出溼性 AMD 具有良好的耐受性和臨床活性
BRTX: 74% | BioRestorative Therapies Presented At The Orthopaedic Research Society 2024 Annual Meeting, Which Describes Preliminary 26 And 52 Week Blinded Data From The Ongoing Phase 2 Trial Of BRTX-100, In Subjects With Chronic Lumbar Disc Disease
BRTX：74% | 在骨科研究學會 2024 年年會上發表的生物修復療法，該會議描述了正在進行的針對慢性腰椎間盤疾病受試者的 BRTX-100 2 期試驗的 26 周和 52 周初步盲檢數據
CDIO: 33% | Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
CDIO：33% | 總部位於休斯敦的ReStor長壽診所將提供心臟診斷的人工智能驅動的表觀遺傳學心臟病測試
譯文內容由第三人軟體翻譯。